Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$5.65B
sum of reported positions
Reported positions
543
Changes vs prior quarter
567
60 new · 52 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 344 measured positions in 8 quarters, the typical new or larger position finished −1.0 pts against the S&P 500 and 48% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 592K | $72.4M | 1.3% | |
| 109K | $62.8M | 1.1% | |
| 652K | $62.7M | 1.1% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $4.72B | $5.65B |
| Positions | 535 | 543 |
| Biggest line | — | Mercury Systems 1% |
| 848K |
| $62.4M |
| 1.1% |
| 565K | $55M | 1.0% |
| 690K | $48M | 0.8% |
| 659K | $47.7M | 0.8% |
| 1.58M | $47.2M | 0.8% |
| 611K | $46.4M | 0.8% |
| 1.63M | $45.7M | 0.8% |
| 149K | $44.2M | 0.8% |
| 545K | $42.7M | 0.8% |
| 112K | $42.4M | 0.7% |
| 426K | $41.5M | 0.7% |
| 172K | $40.1M | 0.7% |
| 357K | $40.1M | 0.7% |
| 234K | $37.6M | 0.7% |
| 540K | $37.6M | 0.7% |
| 227K | $37.3M | 0.7% |
| 601K | $36.8M | 0.7% |
| 230K | $35.7M | 0.6% |
| 345K | $34.4M | 0.6% |
| 660K | $34.4M | 0.6% |
| 670K | $34.3M | 0.6% |
| 479K | $33.4M | 0.6% |
Lpl Financial (LPLA)
20K → 29K shares (+43%)
Kelly Services (KELYA)
676K → 663K shares (−2%)
Red Violet (RDVT)
127K → 125K shares (−2%)
Diodes Incorporated (DIOD)
171K → 72K shares (−58%)
Disc Medicine (IRON)
108K → 107K shares (−1%)
Rimini Street (RMNI)
1.82M shares
Centene Corporation (CNC)
123K → 121K shares (−1%)
Willdan Group (WLDN)
84K → 97K shares (+17%)
Abeona Therapeutics (ABEO)
1.26M → 1.24M shares (−2%)
Enovis (ENOV)
106K → 365K shares (+245%)
Ventas (VTR)
88K → 85K shares (−3%)
Veeco Instruments Inc. (VECO)
230K → 98K shares (−57%)
Vistance Networks (VISN)
592K → 581K shares (−2%)
TruBridge, Inc.
284K → 279K shares (−2%)
Powell Industries, Inc. (POWL)
9,211 → 25K shares (+176%)
Ultragenyx Pharmaceutical (RARE)
219K → 216K shares (−2%)
Evergy (EVRG)
83K shares
Jazz Pharmaceuticals (JAZZ)
18K → 30K shares (+69%)
Brown & Brown (BRO)
145K → 112K shares (−23%)
Cto Realty Growth (CTO)
335K → 330K shares (−2%)
Legacy Education (LGCY)
615K → 603K shares (−2%)
Puma Biotechnology (PBYI)
890K → 873K shares (−2%)
National Presto Industries, Inc. (NPK)
58K → 57K shares (−2%)
Aramark (ARMK)
122K shares
Maravai Lifesciences Holdings (MRVI)
1.11M shares
